Amwell co-founder Roy Schoenberg leaves board
American Well Corporation reports that co-founder Dr. Roy Schoenberg has resigned from its Board of Directors, effective May 6, 2026.
Rhea-AI Filing Summary
American Well Corporation reports that co-founder Dr. Roy Schoenberg has resigned from its Board of Directors, effective May 6, 2026. The company explains that he is leaving in connection with a new employment opportunity.
His resignation is described as not resulting from any disagreement with American Well on operations, policies, or procedures. The company highlights his nearly twenty years of leadership, including service as Executive Vice Chairman of the Board, and credits him with a lasting impact on its growth and evolution.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Figures
Resignation effective date: May 6, 2026
Filing signatory: Anna Nesterova
2 metrics
Resignation effective date
May 6, 2026
Board resignation of co-founder Dr. Roy Schoenberg
Filing signatory
Anna Nesterova
Deputy General Counsel, Head of Legal signed on behalf of American Well
Key Terms
Item 5.02 Departure of Directors or Certain Officers, Emerging growth company, Board of Directors, Executive Vice Chairman of the Board
4 terms
Item 5.02 Departure of Directors or Certain Officers regulatory
"Item 5.02 Departure of Directors or Certain Officers; Election of Directors"
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Board of Directors financial
"resignation from the Company’s Board of Directors, effective immediately"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
Executive Vice Chairman of the Board financial
"both a co-founder and Executive Vice Chairman of the Board"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did American Well (AMWL) disclose in this 8-K filing?
American Well disclosed that co-founder Dr. Roy Schoenberg resigned from its Board of Directors effective May 6, 2026. The company stated his departure is tied to a new employment opportunity and not to any disagreement over operations, policies, or procedures.
Who is Dr. Roy Schoenberg in relation to American Well (AMWL)?
Dr. Roy Schoenberg is a co-founder of American Well and served as Executive Vice Chairman of the Board. The company credits his nearly twenty years of leadership and vision with significantly shaping its growth, evolution, and overall success in the telehealth market.
When did Dr. Roy Schoenberg’s resignation from AMWL’s board become effective?
Dr. Roy Schoenberg’s resignation from American Well’s Board of Directors became effective immediately on May 6, 2026. The 8-K notes that he informed the company of his decision on that date in connection with pursuing a new employment opportunity.
Did Dr. Roy Schoenberg leave American Well (AMWL) because of a disagreement?
American Well explicitly states that Dr. Roy Schoenberg’s resignation was not due to any disagreement with the company. This includes no disagreement over its operations, policies, or procedures, and frames his departure as related instead to a new employment opportunity.
What role did Dr. Roy Schoenberg previously hold at American Well (AMWL)?
Dr. Roy Schoenberg previously served as Executive Vice Chairman of American Well’s Board of Directors. The company highlights his nearly two decades of leadership and recognizes his enduring impact on its strategic direction, growth, and evolution as a telehealth provider.
How does American Well (AMWL) characterize Dr. Roy Schoenberg’s contributions?
American Well describes Dr. Schoenberg’s contributions as nearly twenty years of leadership and vision. It credits him as a co-founder who played a major role in the company’s growth, evolution, and success, and publicly expresses gratitude for his service on the Board.
AI-generated analysis. How Rhea-AI works. Not financial advice.
